Navigation Links
Herceptin May Carry Higher Heart Risks for Women Than Thought
Date:11/15/2012

By Kathleen Doheny
HealthDay Reporter

THURSDAY, Nov. 15 (HealthDay News) -- The risks of developing heart problems while taking the breast cancer drug Herceptin alone or with other anti-cancer drugs may be even higher for older women than thought, new research indicates.

Herceptin (trastuzumab) has long been used to treat breast cancers that overproduce HER-2, also known as human epidermal growth factor. The drug improves disease-free and overall survival, but experts have known that it increases the risk of heart failure because it can affect the ability of the heart to pump blood. It can also raise the chances of developing cardiomyopathy, where the heart muscle becomes enlarged or rigid.

Now, a new study that focused on women aged 67 and older has found that the risk may be higher than believed. The report is published online Nov. 14 in the Journal of the American College of Cardiology.

For older women, the message is this, said study leader Dr. Jersey Chen, an assistant professor of cardiology at the Yale University School of Medicine: "You should know that your risk of developing heart failure or cardiomyopathy may be higher than what is quoted to you [by your doctor]."

Those earlier estimates, Chen said, are based on clinical trials that mainly looked at younger and, in some cases, healthier women.

In those studies, the risk of heart failure, for instance, increased by about 1.6 percent for women on Herceptin. In Chen's new research, the team found that Herceptin or Herceptin given with the anti-cancer drugs known as anthracyclines, raise the risk of either heart failure or cardiomyopathy by about 9 percent in the first year compared to no chemotherapy.

Chen looked at more than 45,000 women, aged 67 and older, who had early-stage breast cancer and were treated with a variety of regimens from 2000 to 2007.

The researchers followed them for three years to see who developed heart problems.

The rates of either heart failure or cardiomyopathy were higher for those getting Herceptin and anthracyclines, either separately or together, than those who did not receive chemotherapy.

Put in other terms, for every 100 patients, 32 of those on Herceptin and 42 of those on Herceptin and anthracycline had developed cardiac problems by the three-year mark, compared to 19 of every 100 patients who did not get adjuvant therapy.

Women who are on these therapies, Chen said, may need to seek additional monitoring. They should discuss the risks and benefits of the treatment with their doctors.

Women should also put these risks in perspective, said Dr. Xianglin Du, a professor of epidemiology at the University of Texas Health Science Center at Houston who has also studied cardiac problems linked with the drugs.

"Overall, their findings were consistent with what were found in our study published a year ago," she said. "Because many studies demonstrated that the addition of trastuzumab to chemotherapy significantly prolongs survival, women with breast cancer are advised to talk to their oncologists to weigh the benefits against potential risks for a better informed decision."

She agreed that closer monitoring may be needed.

The study was funded by the American Heart Association and a collaborative agreement by Memorial Sloan-Kettering Cancer Center. One co-author is a consultant to Celegene, GlaxoSmithKline, Abraxis Bioscience, GTX, Amgen and Genentech.

More information

To learn more about Herceptin, visit the U.S. National Library of Medicine.

SOURCES: Jersey Chen, M.D., M.P.H., assistant professor, cardiology, Yale University School of Medicine, New Haven, Conn.; Xianglin Du, M.D., Ph.D., professor, epidemiology, University of Texas Health Science Center, Houston; Nov. 14, 2012, Journal of the American College of Cardiology, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. African Chimps Carry Drug-Resistant, Human-Linked Staph
2. Some Schools Dont Let Kids Carry Asthma Inhalers
3. People Carrying Guns May Appear Bigger Than They Are
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. Higher proportion of California children uninsured than in US, USC analysis shows
6. Diabetic patients have higher prevalence of hearing impairment
7. Job stress and mental health problems contribute to higher rates of physician suicide
8. Pregnant Women With Bipolar Disorder May Have Higher Risk of Premature Birth
9. Common Antidepressants Tied to Higher Bleeding Risk in Warfarin Users: Study
10. Heart Failure Patients May Be at Higher Risk for Cancer: Study
11. Higher dietary glycemic load linked to worse colon cancer survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Herceptin May Carry Higher Heart Risks for Women Than Thought 
(Date:2/19/2017)... ... 2017 , ... "At your fingertips" electronic access to patient ... Delaware Health Information Network (DHIN) have partnered to improve connectivity of this data ... exchange, DHIN stores and shares real-time health data for more than 2 million ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, ... in the industry, according to the recent NEJM Catalyst Insights Report on the ... the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is a ... Davidson, NC. Dr. Brian Seese leads the practice as a skilled and highly credentialed ... roof. Smiles by Seese serves patients of all ages with excellence in general, restorative, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network ... prescribing of controlled and non-controlled substances plus the ability to manage orders on ... United States now accept electronic prescriptions, according to the Office of the National ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 20, 2017 This report analyzes the worldwide markets ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , and Rest of ... Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
(Date:2/20/2017)... , February 20, 2017 The ... available on AskLinkerReports.com is a comprehensive analysis of the PSA ... Oxygen Concentrators to definition, classification, application, and industry chain overview ... feasibility analysis, new project SWOT analysis, and investment return analysis ... ...
(Date:2/20/2017)... , Feb. 20, 2017   Orion Health ... Amadeus precision medicine platform to the Amazon ... manages over 110 million patient records globally. ... cloud-based, big data solutions built on modern, scalable technology," ... and Life Sciences. "The AWS Cloud gives healthcare companies ...
Breaking Medicine Technology: